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Immunoglobulin A (IgA) nephropathy associated with cirrhosis is the most common
form of secondary IgA nephropathy (IgAN). Cirrhosis-related IgAN is usually clinically
silent with a rare occurrence of gross hematuria, unlike in cases of idiopathic IgAN.
Especially, acute tubular necrosis (ATN) associated with gross hematuria is very rare
in cirrhosis-related IgAN, although acute renal failure is a frequently reported
complication in advanced cirrhosis. Herein, we report an unusual case of ATN
requiring renal replacement therapy, associated with gross hematuria in a patient
with nonalcoholic, hepatitis B virus-associated cirrhosis. Results of a histopathologi-
cal analysis revealed obstruction of the lumen of renal tubules by red blood cell casts,
a marked tubular necrosis, and IgA deposition in the mesangium. The patient’s renal
function and gross hematuria were clearly improved after lamivudine treatment.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Glomerular abnormalities in immunoﬂuorescence and
electron microscopic analysis have been noted in more than
50% of patients with cirrhosis while performing an autopsy
and renal biopsy [1]. Although cirrhosis has been associated
with a variety of glomerular lesions, mesangial proliferation
with immunoglobulin A (IgA) deposition is frequently
reported [1]. This cirrhosis-related IgA nephropathy (IgAN)
is the most common form of secondary IgAN [1,2].
Cirrhosis-related IgAN is usually clinically silent, and labora-
tory abnormalities have been reported in only 10–20% of
patients with cirrhosis [1]. Microscopic hematuria may occur,rean Society of Nephrology. P
ses/by-nc-nd/4.0/).
ology, Konkuk University
ngjin-gu, Seoul, 143-729,but gross hematuria rarely occurs [1,3,4]. Clinically evident renal
failure is also uncommon [1,5]. In particular, acute renal failure
(ARF) is clearly exceptional in patients with IgAN secondary to
hepatitis B virus (HBV)-associated cirrhosis, although ARF is a
common occurrence in patients with cirrhosis [6,7]. In contrast
to idiopathic IgAN, in which ARF can occur during episodes of
gross hematuria, cirrhosis-related IgAN rarely showed ARF
associated with gross hematuria [1]. To our knowledge, acute
tubular necrosis (ATN) associated with gross hematuria in HBV-
associated cirrhosis has not been reported. We report, herein,
an unusual case of ATN associated with gross hematuria in a
patient with IgAN secondary to HBV-associated cirrhosis.Case report
A 59-year-old woman was admitted to the hospital with
the passage of dark urine, which had developed 7 days ago.ublished by Elsevier. This is an open access article under the CC BY-NC-
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tract infection. She had been previously diagnosed with
nonalcoholic HBV-related cirrhosis and chronic renal impair-
ment. There was no familial history of liver or renal disease.
On admission, her body temperature was 36.5 1C and
blood pressure was 117/65 mmHg. Her physical examination
revealed periorbital swellings, ascites, pretibial pitting edema,
and a maculopapular rash on both lower extremities. Laboratory
investigations yielded the following measurements: hemoglo-
bin, 10.9 g/dL; white blood cells, 5,420/mm3; platelets, 71,000/
mm3; prothrombin time, 16.2 seconds; blood urea nitrogen,
24.8 mg/dL; creatinine, 1.9 mg/dL; sodium, 130 mEq/L; potas-
sium, 3.8 mEq/L; chloride, 97 mEq/L; total bilirubin, 0.7 mg/dL;
alkaline phosphatase, 111 IU/L; g-glutamyltransferase, 111 IU/L;
aspartate aminotransferase, 37 IU/L; alanine aminotransferase,
9 IU/L; total protein, 6.1 g/dL; albumin, 2.4 g/dL; and globulin,
3.7 g/dL. Urinalysis revealed blood 3þ , protein 3þ , red blood
cell (RBC) casts, and dysmorphic RBC. A 24-hour urinary protein
excretion was 2,640 mg/day. Results of immunological studies
revealed the following measurements: IgG, 1,828 mg/dL; IgA,
655.9 mg/dL; IgM, 204.9 mg/dL; complement 3, 63.04 mg/dL;
complement 4, 18.73 mg/dL; and hemolytic complement 50,
11.8 U/mL. Antistreptolysin antibodies, cryoglobulins, and anti-
neutrophil cytoplasmic antibody were negative. Antinuclear
antibody was positive, but anti-dsDNA antibody was negative.
Hepatic serologic testing was positive for hepatitis B surface
antigen, hepatitis B envelope antigen, and hepatitis B envelope
antibody. The HBV DNA titer was 4.19105 copies/mL. An
abdominal ultrasound showed normal-sized kidneys, a coarse
liver parenchyma with an irregular surface, moderate ascites,
and splenomegaly. The Child–Pugh score was 8. The serum
ascites albumin gradient was 1.26. A daily treatment with
furosemide (40 mg) and spironolactone (100 mg) was initiatedFigure 1. Renal biopsy ﬁndings. (A) Light microscopic examination (Ma
cellularity with mild expansion of mesangial matrix. Red blood cell casts c
present in the interstitium. (B) Light microscopic examination (hematoxylin
border with epithelial atrophy and regenerating epithelial cells. (C) Immun
mesangial depositions of IgA are identiﬁed. (D) Electron microscopic exam
degenerated and wrinkled. The mesangial matrix is increased with a few
Epithelial foot processes are mildly effaced.after a large-volume paracentesis was performed. On the 8th
day of hospitalization, an upper gastrointestinal endoscopy was
performed due to an anemia aggravation, which showed
esophageal varices without any evidence of active bleeding. In
order to prevent bleeding, a nonselective b-adrenergic blocker
treatment was initiated, following an endoscopic variceal liga-
tion. In addition, lamivudine treatment was started with an
initial dose of 100mg once daily, which was continued for
8 months thereafter.
A percutaneous kidney biopsy was performed on day 13
because of the remarkable reduction in renal function and
persistent gross hematuria. The serum creatinine level on day
13 was 4.4 mg/dL. A light microscopic analysis revealed an
increase in the mesangial matrix and proliferation of mesangial
cells (Fig. 1A). There were no sclerotic glomeruli. RBC casts
were seen in the renal tubules. Some renal tubules showed
typical signs of tubular necrosis, such as tubular epithelial cell
atrophy, loss of brush border, and regeneration of the epithelial
cells (Fig. 1B). Immunoﬂuorescence studies demonstrated
diffuse mesangial deposits of IgA, IgM, and complement 3
(Fig. 1C). Electron microscopic examination revealed a few
electron-dense deposits in the mesangial matrix, paramesan-
gial deposits, and mildly effaced foot processes (Fig. 1D).
Hemodialysis was started on day 30 because the renal
function continued to deteriorate, and the patient developed
uremic symptoms. On day 30, the serum creatinine level was
8.5 mg/dL and gross hematuria was noted. The patient was
discharged on week 7. Regular hemodialysis was continued for
approximately 3 months. Thereafter, hemodialysis was per-
formed two times per week for 2 months, and then stopped.
The serum creatinine level was 2.4 mg/dL when hemodialysis
treatment was stopped. Thereafter, renal function had com-
pletely returned to the baseline levels. Gross hematuria andsson trichrome, 400 ) shows that the glomeruli have an increased
an be seen in the renal tubules. Mild inﬁltrate of mononuclear cells is
and eosin, 400 ) shows that some of the tubules show a loss of brush
oﬂuorescence staining for immunoglobulin A (IgA) shows that diffuse
ination (10,000 ) shows that the glomerular basement membrane is
electron-dense deposits and paramesangial deposits are also noted.
Figure 2. The clinical course. HBV, hepatitis B virus; HD, hemodialysis; HPF, high power ﬁeld; RBC, red blood cells.
Jo et al / ATN in cirrhosis-related IgAN 45proteinuria had disappeared by weeks 8 and 12 of onset,
respectively, but microscopic hematuria continued to persist.
After 8 months of treatment with lamivudine, the HBV DNA
titer had decreased to 1.29103 copies/mL (Fig. 2).Discussion
Mesangial IgA deposition associated with chronic liver
disease is the most common form of secondary IgAN [1,2].
In an autopsy series, predominant mesangial IgA deposits
were found in 36% of the 75 patients with cirrhosis [8].
Although various causes of liver disease such as hepatitis B
and C virus can induce IgAN, it occurs most commonly with
alcoholic cirrhosis [1,9]. However, pathogenesis of IgAN in
advanced liver disease remains poorly understood. Impaired
removal of IgA-containing complexes by the Kupffer cells in
the liver is thought to predispose to IgA deposition in the
kidney in patients with cirrhosis [10].
Unlike idiopathic IgAN, IgAN secondary to HBV-associated
cirrhosis has usually no clinical signs of glomerular disease
[1,2,9]. Microscopic hematuria and subnephrotic-range pro-
teinuria may occur, but gross hematuria and overt nephrotic
syndrome rarely occurs in spite of the frequency of glomer-
ular IgA deposits in advanced liver disease [1,2,5,9]. In addi-
tion, clinically evident renal failure is uncommon, although
ARF is a common complication associated with cirrhosis
[5–7]. ARF can occur during episodes of gross hematuria in
patients with idiopathic IgAN [11]. ARF associated with gross
hematuria is very uncommon in cirrhosis-related IgAN [1,6].
To our knowledge, our case is the ﬁrst report of ARF asso-
ciated with gross hematuria in IgAN secondary to HBV-related
cirrhosis.
In our case, ARF was preceded by gross hematuria with
signs of glomerular bleeding such as RBC casts and a dys-
morphic appearance of some red cells. A renal biopsy revealed
typical evidence of ATN, such as distension of many renal
tubules by intratubular red cells and tubular cell injury. Theseﬁndings are similar to those described in an earlier study
wherein idiopathic IgAN with ARF following bouts of gross
hematuria has been reported [1]. Although the association of
ATN with gross hematuria in patients with IgAN is not clearly
understood, ATN may be induced by the iron released from
lysed red cells in the tubules, possibly acting via the local
generation of toxic oxygen-free radicals [11,12].
Dialysis may be temporarily required in idiopathic IgAN
patients with ARF and gross hematuria [11]. However, the
serum creatinine concentration typically returns to baseline
levels within several weeks/months, although there may be an
incomplete recovery of renal function [11,12]. Signiﬁcant risk
factors for the lack of complete recovery were duration of gross
hematuria longer than 10 days, age greater than 50 years,
decreased estimated glomerular ﬁltration rate at baseline, and
more severe tubular necrosis on renal biopsy [13]. In addition,
very recently, Moreno et al. reported that older patients seemed
to have longer duration of gross hematuria and recovery period
[13]. In our case, despite the risk factors for the lack of complete
recovery of renal function, the serum creatinine concentration
returned to baseline levels within 5 months.
It has been recently reported that there was a complete
remission of nephrotic syndrome by lamivudine therapy in
HBV-associated membranoproliferative glomerulonephritis and
membranous nephropathy in patients with cirrhosis [14,15].
These previous reports suggested the possible role of lamivudine
in the treatment of HBV-associated glomerulopathy. Although the
possibility of spontaneous remission cannot be totally excluded,
the resolution of proteinuria in parallel with rapid reduction in
viremia level was most likely caused by lamivudine therapy.
In conclusion, our case is the ﬁrst report of ARF associated
with gross hematuria in a patient with IgAN secondary to
HBV-related cirrhosis. Despite the risk factors for the lack of
complete recovery of renal function, the patient’s renal func-
tion and nephritic syndrome were completely recovered after
the treatment with lamivudine. However, further studies are
needed to investigate the beneﬁcial effect of lamivudine
therapy in IgAN secondary to HBV-related cirrhosis.
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